Journal of Gastric Cancer

The Korean Gastric Cancer Association (대한위암학회)
권호 표지
DOI QR코드

DOI QR Code

Five-Year Survival of Alpha-Fetoprotein-Producing Gastric Cancer with Synchronous Liver Metastasis: A Case Report

  • Koneri, Kenji (Department of Gastroenterological Surgery, University of Fukui) ;
  • Hirono, Yasuo (Department of Gastroenterological Surgery, University of Fukui) ;
  • Fujimoto, Daisuke (Department of Gastroenterological Surgery, University of Fukui) ;
  • Sawai, Katsuji (Department of Gastroenterological Surgery, University of Fukui) ;
  • Morikawa, Mitsuhiro (Department of Gastroenterological Surgery, University of Fukui) ;
  • Murakami, Makoto (Department of Gastroenterological Surgery, University of Fukui) ;
  • Goi, Takanori (Department of Gastroenterological Surgery, University of Fukui) ;
  • Iida, Atsushi (Department of Gastroenterological Surgery, University of Fukui) ;
  • Katayama, Kanji (Cancer Care Promotion Center, University of Fukui) ;
  • Yamaguchi, Akio (Department of Gastroenterological Surgery, University of Fukui)
  • Received : 2013.01.31
  • Accepted : 2013.02.13
  • Published : 2013.03.30
Download PDF
⟨ Previous Next ⟩

Abstract

Alpha-fetoprotein-producing gastric cancer is associated with poor prognosis because of frequent liver and lymph node metastasis. We present a case with synchronous liver metastasis who survived for 5 years. A 69-year-old man with upper abdominal pain was referred to our hospital. Gastrointestinal endoscopy revealed a Borrmann II-like tumor in the lower part of the stomach. Computed tomography revealed a tumor in the left lobe of the liver. Serum alpha-fetoprotein levels were markedly increased. We performed distal gastrectomy after administering oral tegafur/gimeracil/oteracil potassium and administered hepatic intra-arterial cisplatin injection. Liver metastasis showed partial response on computed tomography. Despite left hepatic lobectomy, further metastases to the liver and mediastinal lymph nodes became difficult to control. After sorafenib tosylate administration, stabilization of the disease was observed for 4 months. We conclude that hepatic intra-arterial chemotherapy and oral administration of sorafenib tosylate may potentially improve the prognosis in such cases.

Keywords

References

  1. Chun H, Kwon SJ. Clinicopathological characteristics of alpha-fetoprotein-producing gastric cancer. J Gastric Cancer 2011;11:23-30. https://doi.org/10.5230/jgc.2011.11.1.23
  2. Kono K, Amemiya H, Sekikawa T, Iizuka H, Takahashi A, Fujii H, et al. Clinicopathologic features of gastric cancers producing alpha-fetoprotein. Dig Surg 2002;19:359-365. https://doi.org/10.1159/000065838
  3. Ishigami S, Natsugoe S, Nakashima H, Tokuda K, Nakajo A, Okumura H, et al. Biological aggressiveness of alpha-fetoprotein (AFP)-positive gastric cancer. Hepatogastroenterology 2006;53:338-341.
  4. Adachi Y, Tsuchihashi J, Shiraishi N, Yasuda K, Etoh T, Kitano S. AFP-producing gastric carcinoma: multivariate analysis of prognostic factors in 270 patients. Oncology 2003;65:95-101. https://doi.org/10.1159/000072332
  5. Kochi M, Fujii M, Kaiga T, Takahashi T, Morishita Y, Kobayashi M, et al. FLEP chemotherapy for alpha-fetoproteinproducing gastric cancer. Oncology 2004;66:445-449. https://doi.org/10.1159/000079498
  6. Inoue M, Sano T, Kuchiba A, Taniguchi H, Fukagawa T, Katai H. Long-term results of gastrectomy for alpha-fetoproteinproducing gastric cancer. Br J Surg 2010;97:1056-1061. https://doi.org/10.1002/bjs.7081
  7. Asami T, Kokawa A, Sugimori K, Tomita N, Shirato K, Morimoto M, et al. A case of AFP-producing gastric cancer with multiple liver metastases responding to CPT-11 and cisplatin combination chemotherapy. Gan To Kagaku Ryoho 2002;29:1985- 1988.
  8. Yoshioka M, Inoue N, Someda H, Noguchi M, Sawada M, Azuma K, et al. A case of AFP-producing gastric cancer resected after efficient S-1/CDDP combination chemotherapy. Gan To Kagaku Ryoho 2011;38:105-108.
  9. Sakurai N, Yamauchi J, Fukushima N, Shibuma H, Ikeda E, Sasou S. A case of non-recurred long-term survival after chemotherapy for liver metastasis of AFP-producing gastric carcinoma. Jpn J Gastroenterol Surg 2005;38:418-423. https://doi.org/10.5833/jjgs.38.418
  10. Nagahama T, Maruyama M, Toukairin Y, Baba H, Yoshida T, Kure N, et al. Hepatic arterial injection therapy (HAI) for metastatic liver tumor from gastric cancer. Gan To Kagaku Ryoho 2000;27:1920-1923.
  11. Takada J, Kenno S, Aoki T, Hamada H, Katsuki Y. A case in which intra-arterial chemotherapy for simultaneous hepatic metastases markedly improved AFP-producing gastric cancer. Gan To Kagaku Ryoho 2009;36:2326-2329.
  12. Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, et al; SHARP Investigators Study Group. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008;359:378-390. https://doi.org/10.1056/NEJMoa0708857
  13. Kim C, Lee JL, Choi YH, Kang BW, Ryu MH, Chang HM, et al. Phase I dose-finding study of sorafenib in combination with capecitabine and cisplatin as a first-line treatment in patients with advanced gastric cancer. Invest New Drugs 2012;30:306-315. https://doi.org/10.1007/s10637-010-9531-2
  14. Amemiya H, Kono K, Mori Y, Takahashi A, Ichihara F, Iizuka H, et al. High frequency of c-Met expression in gastric cancers producing alpha- fetoprotein. Oncology 2000;59:145-151. https://doi.org/10.1159/000012152
  15. Gao JJ, Inagaki Y, Xue X, Qu XJ, Tang W. c-Met: a potential therapeutic target for hepatocellular carcinoma. Drug Discov Ther 2011;5:2-11. https://doi.org/10.5582/ddt.2011.v5.1.2

Cited by

  1. New adjuvant design using layered double hydroxide for production of polyclonal antibodies in radioimmunoassay techniques vol.301, pp.1, 2013, https://doi.org/10.1007/s10967-014-3155-5
  2. Successful multimodal therapy for an α-fetoprotein-producing gastric cancer patient with simultaneous liver metastases vol.10, pp.5, 2015, https://doi.org/10.3892/ol.2015.3731
  3. Synergistic effect and drug‐resistance relief of paclitaxel and cisplatin caused by Co‐delivery using polymeric micelles vol.132, pp.6, 2013, https://doi.org/10.1002/app.41440
  4. Significant response to ramucirumab monotherapy in chemotherapy-resistant recurrent alpha-fetoprotein-producing gastric cancer: A case report vol.14, pp.3, 2013, https://doi.org/10.3892/ol.2017.6514
  5. Long-term Survival of a Patient with α−Fetoprotein-Producing Advanced Gastric Cancer after Adjuvant Chemotherapy with S-1 vol.43, pp.5, 2018, https://doi.org/10.4030/jjcs.43.812
  6. Platinum-based chemotherapy via nanocarriers and co-delivery of multiple drugs vol.9, pp.18, 2021, https://doi.org/10.1039/d1bm00879j